MOUNTAIN VIEW, Calif., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) announced today that the journal Nature has published a neuroblastoma study conducted using the company’s high-depth whole human genome sequencing service. The company believes that this is not only the most comprehensive genomic analysis of neuroblastoma published to date, but also the largest whole-genome survey of a single cancer type formally reported in the literature. The paper is available online here.
